Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition; Nearly 1 in 10 teens globally have used ‘budget Ozempic’ laxatives and other risky weight loss products

Taking stock of the drug industry, from the lab to the medicine chest

January 10, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

INA FASSBENDER/AFP via Getty Images STAT+ | Bayer's promising menopause drug trial results highlight growing interest in long-neglected condition Veozah, a non-hormonal hot flash treatment by Astellas, may soon face competition as Bayer reports encouraging clinical trial results for elinzanetant. By Annalisa Merelli Nearly 1 in 10 teens globally have used 'budget Ozempic' laxatives and other risky weight loss products, per study Nearly1 in 10 adolescents around the globe have used non-prescription weight loss products. Experts warn these products pose health risks. By Theresa Gaffney STAT+ | At JPM, Verve details plot to take genome editing mainstream Verve Therapeutics' CEO says the company wants to edit out heart attacks for the millions at risk of severe cardiovascular disease. By Damian Garde Sarah Gonzalez/Peopletography for STAT STAT+ | FDA's Peter Marks seems inclined to grant full approval to Sarepta's Duchenne gene therapy At an event on the sidelines of the J.P. Morgan Healthcare Conference, Marks seemed comfortable with granting some form of full approval to Elevidys. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser